Pediatric Neurology Disorders News

Jul 06, 2020
Fever-associated seizures after vaccination do not affect development, behavior
Parents will be relieved to hear that having a febrile seizure following vaccination does not affect the child's development.
Feb 11, 2020
Discovery could speed diagnosis and treatment of children with life-threatening neurological disease
In the study, 85% (99/116) of children with life-threatening autoimmune conditions had complete or near complete recovery after biomarker was spotted and they were subsequently given appropriate treatment.
Jan 27, 2020
High air pollution exposure in 1-year-olds linked to structural brain changes at age 12
Loss of gray matter volume and cortical thickness may be enough to influence the development of various physical and mental processes.
Jan 17, 2020
Sleep linked to language skills in neurodevelopmental disorders
Study is first to examine relationship among children with Down syndrome, Fragile X syndrome, and Williams syndrome.
Jan 13, 2020
Risk of lead exposure linked to decreased brain volume in adolescents
Researchers reveal a relationship between lead exposure risk and brain structure in children from lower-income families.
Oct 24, 2019
FDA Approves Botox for Lower-Limb Spasticity in Children
Approval marks onabotulinumtoxinA’s 11th therapeutic indication.
Sep 20, 2019
Researchers team up to better understand sleep apnea treatment in children
A fresh look at pediatric sleep studies.
May 28, 2019
Music helps to build the brains of very premature babies
Researchers from UNIGE and HUG demonstrate how music specially composed for premature infants strengthens the development of their brain networks and could limit the neurodevelopmental delays that often affect these children.
May 17, 2019
FDA approves first anticoagulant to treat potentially life-threatening blood clots in children
First anticoagulant indicated for pediatric patients approved by the FDA.
Apr 28, 2019
FDA approves first treatment for pediatric patients with lupus
Drug fulfils unmet need for therapies, specifically in pediatric patients with systemic lupus erythematosus.
Next ▶